The residency is a 12-month, ASHP-pre-accredited, post-graduate program
that begins around July 1 annually. We accept one resident yearly. Application
deadline is Jan. 15. Early commit for KD PGY1 resident available.
Antimicrobial Stewardship and Practice Management (11 months)
Infectious Diseases Clinic (10 months; every Friday)
Research (12 months)
Staffing (11 months; every third weekend)
ELECTIVE ROTATIONS - 4 Weeks Each
Critical Care
Infectious Diseases Clinic
Outpatient Parenteral Antimicrobial Therapy
PGY2 SAMPLE SCHEDULE
PROGRAM COMPLETION REQUIREMENTS
Function as independent pharmacists.
Attain an “achieved for residency” on 95% of the objectives
as assessed by the Residency Program Director on the last quarterly evaluation.
100% of the Patient Care objectives must be marked as “achieved
for residency.” In order to successfully complete the program, no
areas should be marked as “needs improvement” by the residency end date.
Complete a yearlong research project.
Complete a manuscript suitable for publication and receive approval from
the project preceptor(s) and Residency Program Director.
Participate in development of the annual antibiogram and treatment guidelines.
Document coverage of all required topics from the PGY2 ID topic list.
Prepare and present two ACPE or equivalent education sessions.
Demonstrate active participation in the residency learning system/process
through participation in the evaluations of the program, learning experiences,
preceptors and self-evaluations.
Attend required professional meetings.
Participate in the recruitment efforts of the program.
Residents are expected to attend and actively participate in recruitment
events to which they are assigned.
Participate in teaching certificate program if not completed during PGY1
(offered through Marshall University School of Pharmacy).
Participate in four professional/community service events.
Prepare and participate in P&T Committee meeting presentations.
Participate in Antimicrobial Stewardship (ASC), Diagnostic Stewardship
(DxSt), and Infection Control committee meetings.
Other responsibilities may arise during the residency year. The Residency
Program Director and the resident will discuss these as they arise.
STAFFING REQUIREMENTS (EVERY THIRD WEEKEND)
Verification of antimicrobial orders
Interventions to improve antimicrobial selection and dose optimization
Antimicrobial stewardship activities
STIPEND
PGY2: $56,678
JACOB OSBORNE, PHARM.D., MBA PGY2 Infectious Diseases Resident 2023-24
Dr. Osborne is the current PGY2 Pharmacy Resident in Infectious Diseases
and a 2022 graduate of the University of Kentucky College of Pharmacy.
He also earned his Master in Business Administration from the University
of Kentucky Gatton College of Business in 2022. He completed his PGY-1
residency at KDMC in 2023. Dr. Osborne’s areas of research interest
are antimicrobial stewardship, HIV medication management, and Hepatitis
C screening initiatives. Upon completion of the PGY2 residency, Dr. Osborne
plans to work in an Infectious Diseases clinic and assist in the treatment
of patients infected with HIV and/or Hepatitis C.
